Organization Profile

You just read:

Augurex Announces Exclusive License Agreement with Quest Diagnostics for the Development of Arthritis Biomarker 14-3-3η as a Testing Service in the U.S.

News provided by

Augurex Life Sciences Corp.

Oct 09, 2012, 15:59 ET